Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies.
Ann Oncol
; 26(5): 998-1005, 2015 May.
Article
in En
| MEDLINE
| ID: mdl-25609248
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Carcinoma, Non-Small-Cell Lung
/
STAT3 Transcription Factor
/
Lung Neoplasms
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Limits:
Aged80
Country/Region as subject:
Asia
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2015
Document type:
Article